Zentrum für Neuropathologie und Prionforschung
print

Sprachumschaltung

Navigationspfad


Inhaltsbereich

Dr. med. Alexander Beck

[2019] [2018] [2016] [2014]

2019

Eberherr C, Beck A, Vokuhl C, Becker K, Häberle B, Von Schweinitz D & Kappler R
Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
International journal of oncology, 2019 May, 54 (5) 1853-1863

2018

Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, van Galen P, Bonal DM, Nguyen QD, Beck A, Sinai C, Czech T, Dorfer C, Goumnerova L, Lavarino C, Carcaboso AM, Mora J, Mylvaganam R, Luo CC, Peyrl A, Popović M, Azizi A, Batchelor TT, Frosch MP, Martinez-Lage M, Kieran MW, Bandopadhayay P, Beroukhim R, Fritsch G, Getz G, Rozenblatt-Rosen O, Wucherpfennig KW, Louis DN, Monje M, Slavc I, Ligon KL, Golub TR, Regev A, Bernstein BE & Suvà ML
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.
Science (New York, N.Y.), 2018 Apr 20, 360 (6386) 331-335

Beck A, Trippel F, Wagner A, Joppien S, Felle M, Vokuhl C, Schwarzmayr T, Strom TM, von Schweinitz D, Längst G & Kappler R
Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma.
Clinical epigenetics, 2018, 10 27

2016

Beck A, Eberherr C, Hagemann M, Cairo S, Häberle B, Vokuhl C, von Schweinitz D & Kappler R
Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.
Cancer biology & therapy, 2016 Nov, 17 (11) 1168-1176

2014

Eichenmüller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, Häberle B, Cairo S, Leuschner I, von Schweinitz D, Strom TM & Kappler R
The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
Journal of hepatology, 2014 Dec, 61 (6) 1312-20